Filing Details
- Accession Number:
- 0000904454-11-000619
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-21 20:27:19
- Reporting Period:
- 2011-11-21
- Filing Date:
- 2011-11-21
- Accepted Time:
- 2011-11-21 20:27:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1466301 | Clovis Oncology Inc. | CLVS | Pharmaceutical Preparations (2834) | 900475355 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1374150 | P L Vii Parters Domain | C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-11-21 | 409,192 | $0.00 | 409,192 | No | 4 | C | Direct | |
| Common Stiock | Acquisiton | 2011-11-21 | 409,192 | $0.00 | 818,384 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2011-11-21 | 885,696 | $0.00 | 1,704,080 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2011-11-21 | 370,799 | $0.00 | 2,074,879 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2011-11-21 | 916,058 | $13.00 | 2,990,937 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A-1 Preferred Stock | Disposition | 2011-11-21 | 1,186,657 | $0.00 | 409,192 | $0.00 |
| Common Stock | Series A-2 Preferred Stock | Disposition | 2011-11-21 | 1,186,657 | $0.00 | 409,192 | $0.00 |
| Common Stock | Series B Preferred Stok | Disposition | 2011-11-21 | 2,568,521 | $0.00 | 885,696 | $0.00 |
| Common Stock | Convertible Promissory Note | Disposition | 2011-11-21 | 0 | $0.00 | 370,799 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- All outstanding shares of the Issuer's preferred stock were automatically converted into Common Stock upon the closing of the Issuer's iniital public offering (the "IPO"), for no additional consideration.
- The Convertible Promissory Note plus interest accrued thereon through the closing of the IPO, automatically converted into Common Stock upon the closing of the IPO, based on the IPO price of $13.00 per share.
Billionaire Hedge Funds
